| Product NDC: | 21695-169 |
| Proprietary Name: | Namenda |
| Non Proprietary Name: | memantine hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; memantine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-169 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021487 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041117 |
| Package NDC: | 21695-169-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (21695-169-60) |
| NDC Code | 21695-169-60 |
| Proprietary Name | Namenda |
| Package Description | 60 TABLET in 1 BOTTLE (21695-169-60) |
| Product NDC | 21695-169 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | memantine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20041117 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | MEMANTINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC] |